menu
    • menu

    Company profile for Zetagen Therapeutics

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet™ technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. Zetagen exclusively-licensed the platform technology from the State University of Ne...
    Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet™ technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. Zetagen exclusively-licensed the platform technology from the State University of New York in 2016. This novel therapy, a drug-eluting implant technology, has successfully passed its preclinical trials and is being prepared for its first human clinical trial in Q4 2021.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zetagen TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    841 EFayette St, Syracuse, New York, 13210
    Telephone
    Telephone
    (315) 372-5494
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zetagen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zetagen-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zetagen Therapeutics Completes Oversubscribed Series B1 Round
    Zetagen Therapeutics Completes Oversubscribed Series B1 Round

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125265044/en/Zetagen-Therapeutics-Closes-Oversubscribed-Series-B1-Round-on-Strength-of-Promising-Phase-2a-Data-and-Compelling-Pipeline

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Zetagen Therapeutics To Unveil Phase 2 Trial Results
    Zetagen Therapeutics To Unveil Phase 2 Trial Results

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104508300/en/Zetagen-Therapeutics-to-Present-Preliminary-Results-from-Phase-2-Clinical-Trial-Targeting-Metastatic-Breast-Cancer-to-Bone-at-the-2025-San-Antonio-Breast-Cancer-Symposium

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Zetagen to Present Promising Preclinical Data at SABCS
    Zetagen to Present Promising Preclinical Data at SABCS

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104211483/en/Zetagen-Therapeutics-to-Present-Promising-Preclinical-Data-at-SABCS-Zeta-BC-007-Demonstrates-Superior-Tumoricidal-Activity-and-Survival-Benefit-in-Breast-Cancer-Model

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Zetagen Secures USPTO Patents for Novel Breast Cancer Platform
    Zetagen Secures USPTO Patents for Novel Breast Cancer Platform

    28 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250728989369/en/Zetagen-Therapeutics-Secures-Composition-of-Matter-Patents-from-USPTO-for-Novel-Breast-Cancer-Platform

    BUSINESSWIRE
    28 Jul 2025
    Share Share
    Zetagen Publishes ZetaMast Data in TNBC Liver Metastases
    Zetagen Publishes ZetaMast Data in TNBC Liver Metastases

    17 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250617984021/en/Zetagen-Therapeutics-Announces-Peer-reviewed-Publication-of-In-Vivo-Dose-Optimization-Findings-for-ZetaMast-Zeta-MBC-005-for-Triple-Negative-Breast-Cancer-Liver-Metastases

    BUSINESSWIRE
    17 Jun 2025
    Share Share
    Zetagen Therapeutics Completes Enrollment in ZetaMet Phase 2a Study
    Zetagen Therapeutics Completes Enrollment in ZetaMet Phase 2a Study

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250505965299/en/Zetagen-Therapeutics-Announces-Successful-Completion-of-Enrollment-in-Phase-2a-Clinical-Study-of-ZetaMet-Zeta-BC-003-Metastatic-Breast-Cancer

    BUSINESSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search